Post-IPO Equity Biotechnology Companies

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Decoy Therapeutics is a biotech company that design the next generation of peptide conjugate therapies to protect and expand patient lives.

Medicenna is a clinical stage, privately held, immuno-oncology company.

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Imagion Biosystems is a Biotechnology Company.

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders